Last edition
News about "EBITDA margin"
GSK India Reports 24 Percent PAT Growth in Q1 FY27
GSK India reported 15 percent revenue growth to INR 924 crore and a 24 percent rise in Q1 FY27 PAT to INR 253 crore, with EBITDA margin of 32 percent.
EBITDA Margin | 04/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members